Peripheral Arteriopathy Rate In Stroke

Purpose:

To assess the prevalence of peripheral arterial disease (PAD) in acute stroke patients.

Interventions:

Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).

Design:

Prospective, open, cohort study.

Study size planned:

1500.

Follow-up duration:

3 months.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Peripheral Artery Disease Arterial Occlusive Diseases Arteriosclerosis Atherosclerosis Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Peripheral Arterial Disease Peripheral Vascular Diseases Stroke Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Neurology, University of Erlangen, Germany

Erlangen, 91054, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All consecutive adult patients with acute ischemic or hemorrhagic stroke.

Exclusion criteria

Congestive heart failure.

Treatment and study plan

measuring the ankle brachial index

Procedure

Assessment of the ankle brachial index using the "boso-ABI-system 100" (www.boso.de).

Primary outcomes

Functional outcome (modified Rankin Scale)

Time frame: 3 months

Secondary outcomes

Prevalence of peripheral arterial disease

Time frame: during hospital stay

Presence or not of PAD as assessed using ABI during hospital stay

Sponsors and collaborators

Lead sponsor

University of Erlangen-Nürnberg Medical School

Other

Registry information

Official study title

Prevalence of Peripheral Arterial Disease in Acute Ischemic and Hemorrhagic Stroke Patients

Acronym: PARIS

Important dates

Study start: 2008
Primary completion: 2017
Study completion: 2017
First posted: Nov 19, 2008
Registry last updated: Oct 25, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed